Evidence map›Paper›PMID 42741162›Full record

ArticleFrontiers in neurology2026

Real-world deep brain stimulation programming practices for Parkinson's disease in India: variability, technology adoption, and emerging trends from a multicentre clinician survey across India.

Pramod Kumar Pal, Roopa Rajan, Syam Krishnan Nair, Ravi Yadav, Mohit Anand, Shankar Balakrishnan, Manish Baldia, Anirban Deep Banarjee, Rupam Borgohain, Jacky Ganguly and 19 more

Abstract readMulticenter Study
In one paragraph

Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Pramod Kumar PalDepartment of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Roopa RajanDepartment of Neurology, All India Institute of Medical Sciences (AIIMS), Delhi, India.
Syam Krishnan NairDepartment of Comprehensive Care Centre for Movement Disorders, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, Kerala, India.
Ravi YadavDepartment of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Mohit AnandDepartment of Neurology, Artemis Hospital, Gurgaon, India.
Shankar BalakrishnanDepartment of Neurology, Rela Hospital, Chennai, India.
Manish BaldiaDepartment of Neurosurgery, Wockhardt Hospital, Mumbai, India.
Anirban Deep BanarjeeDepartment of Neurosurgery, Medanta Institute of Neurosciences, Gurgaon, India.
Rupam BorgohainDepartment of Parkinson's and Movement Disorders Research Centre (PDMDRC), Yashoda Hospitals, Hyderabad, India.
Jacky GangulyDepartment of Neurology, Movement Disorder Centre, Institute of Neurosciences Kolkata, India.
Dhanunjay Rao GinjupallyDepartment of Neurosurgery, Apollo Health City, Hyderabad, India.
Vikram V HollaDepartment of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Guruprasad HosurkarDepartment of Neurology, Head of Parkinson's Disease and Movement Disorder Programme, Krishna Institute of Medical Sciences (KIMS) Hospitals, Bangalore, India.
Nitesh KambleDepartment of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Rukmini Mridula KandadaiDepartment of Parkinson's and Movement Disorders Research Centre (PDMDRC), Yashoda Hospitals, Hyderabad, India.
Akshat KayalDepartment of Neurosurgery Kokilaben Dhirubhai Ambani Hospital, Mumbai, India.
Abhijeet Kumar KohatDepartment of Neurology, Dau Kalyan Singh Post Graduate Institute and Research Centre, Raipur, India.
Hrishikesh KumarDepartment of Neurology, Movement Disorder Centre, Institute of Neurosciences Kolkata, India.
Rohan R MahaleDepartment of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Vaibhav MaturDepartment of Neurology and Neurosurgery, Narayana Multispeciality Hospital, Jaipur, India.
Sreeram PrasadAdvanced Center for Movement Disorders and DBS, Rajagiri Hospital, Kochi, Kerala, India.
R Shiva KumarDepartment of Neurology, Manipal Hospital, Bangalore, India.
Atif SheikhDepartment of Neurology, Christian Medical College, Vellore, Tamil Nadu, India.
Kuldeep ShettyDepartment of Neurology, NH Mazumdar Shaw Medical Centre, Bangalore, India.
Sumit SinghDepartment of Neurology, Artemis Hospital, Gurgaon, India.
Anil VenkatachalamDepartment of Neurology, Apollo Hospitals, Navi Mumbai, India.
Vijay ShankarDepartment of Neurology, Apollo Hospitals, Chennai, India.
Kavadisseril Vivekanandan VysakhDepartment of Neurology, Caritas Neuro Sciences, Kottayam, India.
Sireesha YareedaDepartment of Neurology, Nizam's Institute of Medical Sciences (NIMS), Hyderabad, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Deep brain stimulation (DBS) outcomes in Parkinson's disease (PD) are strongly influenced by postoperative programming, yet real-world workflows and adoption of newer technologies, including directional stimulation, sensing-enabled systems, and adaptive DBS, vary across clinical settings. This study aimed to describe contemporary real-world DBS programming practices for PD among clinicians across India. Methods: We conducted an anonymous, cross-sectional, web-based survey of Indian clinicians actively programming DBS for PD with ≥1 year of experience. The survey assessed initial programming workflows, symptom-specific optimization strategies, medication adjustment practices, use of sensing-enabled technologies, approaches to suboptimal response, respondent-level workflow patterns, and perceptions of adaptive DBS. Results were analyzed descriptively using item-specific denominators; multi-select responses were summarized as option-level proportions. Results: Fifty of 54 approached clinicians completed the survey. Respondents represented 37 DBS centres across 18 Indian cities. The subthalamic nucleus was the most commonly selected target (42/50, 84.0%). Stimulation was most often initiated within 1-2 weeks (25/50, 50.0%) or 3-4 weeks (14/50, 28.0%) after implantable pulse generator implantation. Initial programming strategies were captured as a multi-select item; the most frequently selected strategy was a combination of monopolar review and BrainSense (35/50, 70.0%), followed by traditional monopolar review (22/50, 44.0%). Current BrainSense use was reported by 42/50 respondents (84.0%); among current users, initiation most often occurred at initial programming (26/42, 61.9%). Symptom-specific optimization strategies varied by clinical problem: amplitude adjustment was most frequently selected for bradykinesia (42/50, 84.0%) and rigidity (45/50, 90.0%), while frequency adjustment was most frequently selected for tremor (47/50, 94.0%) and freezing of gait (43/50, 86.0%). For suboptimal response, imaging-based lead localization strategies were frequently selected, particularly pre-/post-operative imaging merge with lead location review (44/50, 88.0%). Exploratory respondent-level analysis identified overlapping workflow domains, including sensing-integrated programming (26/50, 52.0%) and technology-assisted troubleshooting (29/50, 58.0%); 31/50 respondents (62.0%) fell into the high workflow/technology-integration score category. Most respondents intended to incorporate adaptive DBS into routine clinical practice (45/50, 90.0%). Conclusion: This multicentre survey provides a snapshot of contemporary DBS programming practices for PD in India, highlighting practice variability, increasing adoption of technology-assisted programming, and strong interest in adaptive DBS. These findings support the need for context-specific training and future outcome-based research.

Indexed as

Deep Brain StimulationParkinson DiseasePractice Patterns, Physicians'Cross-Sectional StudiesFemaleHumansIndiaMaleSurveys and QuestionnairesDBS programmingdeep brain stimulationParkinson’s diseasereal-world evidencesensing-enabled DBS

Identifiers

PMID42741162
PMCPMC13572247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.